Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Law Office of John K. Pike, PLLC
ALEXANDRIA, VA US
1. 20110020321 METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDE AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR 01-27-20112. 20100317745 Bioresorbable Polymers - bioresorbable polymer is obtained by reacting together a prepolymer comprising co-polymerised units of a caprolactone and poly 12-16-2010
3. 20100184091 Method for determining MIF content - diagnostic methods for determining migration inhibitory factor mRNA content in a sample 07-22-2010
4. 20100179225 POI Prevention - method is provided comprising administering at least one guanylhydrazone or salt thereof or a combination thereof to a subject to 07-15-2010
5. 20100137566 Compounds and Methods Used to Treat Infectious Diseases 06-03-2010
6. 20100028690 High-Temperature Non-Skid Coating Composition 02-04-2010
7. 20100016391 Isoxazoline Compounds Having MIF Antagonist Activity 01-21-2010
8. 20090324692 Polyurethane Elastomers - linear polymer is obtained by reacting together a polyethylene glycol or polypropylene glycol 12-31-2009
9. 20090291120 Hydrophilic Polyurethane Compositions - water-swellable linear polymer is made by reacting together a polyethylene oxide of number average molecular 11-26-2009
10. 20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor 10-22-2009
11. 20090036540 Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction 02-05-2009
12. 20090023046 Porous Transport Structures for Direct-Oxidation Fuel Cell System Operating with Concentrated Fuel 01-22-2009
13. 20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity 12-25-2008
14. 20080300529 Skin Care Method and Kit Using Peltier Thermoelectric Device 12-04-2008
15. 20080262090 Guanylhydrazone Salts, Compositions, Processes of Making, and Methods of Using 10-23-2008
16. 20080260723 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor 10-23-2008